Clinical trial
Clinical Studies by Using Alphacait to Screen Drug Combinations for Advanced Solid Tumor
NCT03299452 is registered in ClinicalTrials.gov with Haining Health-Coming Biotech Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Studies by Using Alphacait to Screen Drug Combinations for Advanced Solid Tumor
- Lead sponsor
- Haining Health-Coming Biotech Co., Ltd.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 1, 2017
- Completion date
- December 31, 2020
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
metastatic cancer